• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Diane R. Bielenberg, PhD


  • Catena R, Bhattacharya N, El Rayes T, Wang S, Choi H, Gao D, Ryu S, Joshi N, Bielenberg D, Lee SB, Haukaas SA, Gravdal K, Halvorsen OJ, Akslen LA, Watnick RS, Mittal V.Bone marrow-derived gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1.Cancer Discovery. 2013 May;3(5):578-89.
  • Bielenberg DR, D'Amore PA.All vessels are not created equal.Am J Pathol. 2013 Apr;182(4):1087-91.
  • Shimizu A, Nakayama H, Wang P, K├Ânig C, Akino T, Sandlund J, Coma S, Italiano JE, Mammoto A, Bielenberg DR, Klagsbrun M.Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein.J Biol Chem. 2013 Jan 25;288(4):2210-22.
  • Coughlin MF, Bielenberg DR, Lenormand G, Marinkovic M, Waghorne CG, Zetter BR, Fredberg JJ.Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential.Clin Exp Metastasis. 2012 Sep 8.
  • Hager MH, Morley S, Bielenberg DR, Gao S, Morello M, Holcomb IN, Liu W, Mouneimne G, Demichelis F, Kim J, Solomon KR, Adam RM, Isaacs WB, Higgs HN, Vessella RL, Di Vizio D, Freeman MR.DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.EMBO Mol Med. 2012 Aug;4(8):743-60.
  • Gregory KJ, Zhao B, Bielenberg DR, Dridi S, Wu J, Jiang W, Huang B, Pirie-Shepherd S, Fannon M.Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells.PLoS ONE. 2010;5(10):e13428.
  • Zhang Z, Wang H, Ikeda S, Fahey F, Bielenberg D, Smits P, Hauschka PV.Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.Am J Pathol. 2010 Sep;177(3):1459-69.
  • Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, Ellis LM.Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.Clin Cancer Res. 2009 Nov 15;15(22):6763-70. Review.
  • Yang J,Bielenberg DR,Rodig SJ,Doiron R,Clifton MC,Kung AL,Strong RK,Zurakowski D,Moses MA.Lipocalin 2 promotes breast cancer progression.Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3913-8.
  • Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M.Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.Microvasc Res. 2008 May;76(1):15-22.
  • Bielenberg DR.Metastasis: two assays explore the two roads traveled.Nat Methods. 2008 May;5(5):384-5.
  • Zwaans BM, Bielenberg DR.Potential therapeutic strategies for lymphatic metastasis.Microvasc Res. 2007 Sep-Nov;74(2-3):145-58. Review.
  • Bielenberg DR, Klagsbrun M.Targeting endothelial and tumor cells with semaphorins.Cancer Metastasis Rev. 2007 Dec;26(3-4):421-31. Review.
  • Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M.Neuropilins in neoplasms: expression, regulation, and function.Exp Cell Res. 2006 Mar 10;312(5):584-93. Review.
  • Mamluk R, Klagsbrun M, Detmar M, Bielenberg DR.Soluble neuropilin targeted to the skin inhibits vascular permeability.Angiogenesis. 2005;8(3):217-27.
  • Bielenberg DR, Hida Y, Shimizu A, Kaipainen A, Kreuter M, Kim CC, Klagsbrun M.Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.J Clin Invest. 2004 Nov;114(9):1260-71.
  • Gagnon ML, Bielenberg DR, Gechtman Z, Miao HQ, Takashima S, Soker S, Klagsbrun M.Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2573-8.